CV Sciences, Inc. Repays Remaining Debt
August 22, 2018 08:45 ET
|
CV Sciences, Inc.
LAS VEGAS, Aug. 22, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) announced today that it has fully repaid the promissory note payable...
CV Sciences, Inc. Reports Second Quarter 2018 Financial Results
August 01, 2018 08:45 ET
|
CV Sciences, Inc.
Growth and Profitability Driven by Key Financial Performance Metrics, including Record GAAP Net Income of $3.2 MillionManagement to Host Second Quarter 2018 Financial Results Conference Call on August...
CV Sciences, Inc. to Host Annual Meeting of Shareholders and Investor Day on August 4, 2018 in San Diego, California
July 10, 2018 08:45 ET
|
CV Sciences, Inc.
Company to Feature Guest Speaker, World-Renowned Neurosurgeon and Sports Medicine Expert Dr. Joseph Maroon LAS VEGAS, July 10, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the...
CV Sciences, Inc. Issues Letter to Shareholders
June 27, 2018 08:45 ET
|
CV Sciences, Inc.
LAS VEGAS, June 27, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc., (OTCQB:CVSI) (the "Company," "CV Sciences," "our" or "we"), preeminent manufacturer and distributor of the industry-dominating brand...
CV Sciences, Inc. Announces Landmark Publication on the Toxicology and Safety Assessment of Base Material of its PlusCBD Oil™ Products
June 15, 2018 08:45 ET
|
CV Sciences, Inc.
LAS VEGAS, June 15, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”) announced today the June 7, 2018 publication of the toxicology and safety...
CV Sciences, Inc. Settles SEC Matter
June 01, 2018 08:45 ET
|
CV Sciences, Inc.
The Company Names New Chief Executive Officer, President and Board Member LAS VEGAS, June 01, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”)...
CV Sciences, Inc. Supports World No Tobacco Day on May 31, 2018
May 31, 2018 08:45 ET
|
CV Sciences, Inc.
LAS VEGAS, May 31, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc., (OTCQB:CVSI) (the "Company," "CV Sciences," "our" or "we"), is pleased to announce its support in highlighting the World Health...
CV Sciences, Inc. to Present at 8th Annual LD Micro Invitational on June 4-6, 2018 in Bel-Air, California
May 22, 2018 08:45 ET
|
CV Sciences, Inc.
LAS VEGAS, May 22, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc., (OTCQB:CVSI) (the "Company," "CV Sciences," "our" or "we"), preeminent manufacturer and distributor of the leading brand of hemp...
CV Sciences, Inc. to Host First Quarter 2018 Financial Results Conference Call on Tuesday, May 15, 2018
May 08, 2018 05:45 ET
|
CV Sciences, Inc.
LAS VEGAS, May 08, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc., (OTCQB:CVSI) a preeminent manufacturer and distributor of hemp-derived phytocannabinoids including CBD oil, today announced that it is...
CV Sciences, Inc. Fully Retires Convertible Debt
April 25, 2018 11:08 ET
|
CV Sciences, Inc.
Company Fully Repays Outstanding Convertible Debt and Avoids Dilution to Stockholders LAS VEGAS, April 25, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company,” “CV Sciences,”...